A reverse chronological list of vaccine licensure announcements from FDA, vaccine recommendations from the Advisory Committee on Immunization Practices (ACIP) and CDC, and other resources from government sources. Use filters to narrow your search.
FDA approves Dengvaxia, the first vaccine approved for the prevention of dengue disease in people ages 9 through 16 who have laboratory-confirmed previous dengue infection and who live in endemic areas.
FDA Approval –
May 1, 2019